Embracing the Challenge - Advancing Cancer Care

Urothelial Carcinoma and Emerging ADCs

In our latest podcast we discuss urothelial carcinoma and the latest advances in treating with antibody drug conjugates (ADCs), as a new therapeutic option. Dr Tony Michele, Medical Oncologist from Adelaide Oncology and Haematology, part of the Genesiscare Group, and PCPA Board member is joined by Dr Elizabeth Liow, Medical Oncologist at Monash in Melbourne and Dr Laurence Krieger, Medical Oncologist at Genesis Care North Shore Hub in Sydney. Our podcasters deep experience in managing these patients is invaluable in this transforming field of expertise. https://www.pcpa.org.au/

CAR T-cell Therapy in Australia: Paradigm Changing Technology

In this PCPA Podcast Dr Ian Irving, PCPA Board Member, Haematologist and Chief Medical Officer at ICON Group, discusses CAR T-cell therapy, a transformative approach reshaping the landscape of haematologic malignancies. CAR T-cell therapy leverages a patient's own immune system to target and eradicate cancer cells with remarkable precision. Throughout this episode, we delve into the mechanisms of action, clinical trial data, and practical considerations for integrating CAR T-cell therapy into your practice. Ian is joined by Associate Professor Mary Ann Anderson, Haematologist from the Peter MacCallum Cancer Centre in Melbourne and Dr Allison Barraclough, Haematologist from the Fiona Stanley Hospital in Perth.

Leadership Stories: Women in Oncology Research

In this PCPA Podcast we focus on Leadership Stories: Women in Oncology Research, launched on International Women’s Day 2024. Professor Fran Boyle, Medical Oncologists and Supportive care Physician from the Mater Hospital in Sydney discusses the unique challenges and opportunities with Professor Victoria Atkinson from Greenslopes Private Hospital and the Princess Alexandra Hospital in Brisbane and also Dr Amy Davies, Medical Oncologist and Research Scientist from Victoria. We tackle: Is it necessary to go overseas to progress your career? Can you do great research in the private sector? What are the special qualities and strengths women bring to cancer care? This episode is a powerful tribute to the remarkable women who are shaping the future of cancer research and making a significant impact on the lives of thousands of cancer patients. It's a reminder of the importance of diversity and inclusion in scientific research and the crucial role women play in driving innovation and progress.

The What, When, Why and How of IDH Mutations in Cancer

In this PCPA podcast we discuss The What, When, Why and How of IDH Mutations in Cancer? The discussion covers the understanding of IDH mutations in cancer, a completely new enzyme driving cancer in both solid tumours and in haematology. Experts are on hand to cover the nuances in molecular testing and review current and future therapies and trends in these patient populations. Dr Shehara Mendis, Medical Oncologist from Cabrini Hospital in Melbourne chairs this discussion with Dr Michael Rodriguez, Consultant Neuropathologist, St Vincent's Hospital and POW Hospital Sydney; Douglass Hanly Moir Pathology and Associate Professor Daniel Thomas, a Clinical Haematologist and Cancer Scientist from the University of Adelaide.

Most Patients With Cancer are Older - How Does this Impact their Care?

In this PCPA podcast we discuss “Most Patients With Cancer are Older - How Does this Impact their Care?” The conversation explores this specialised field which focuses on the care of older adults with cancer. Since more than 50% of patients will be over 65 years of age in the next few years and as an oncologist treating older patients with cancer, it's crucial to understand the unique challenges and considerations involved in their care . A/Professor Christopher Steer , medical oncologist from Albury/Wodonga and President of the Private Cancer Physicians of Australia is joined by Dr Etienne Brain, MD, PhD, senior medical oncologist at Institut Curie, in Saint-Cloud, France, who was honoured with the 2022 B.J. Kennedy Geriatric Oncology Award for his career-long contributions to advancing clinical research in breast cancer in older populations.